Results 111 to 120 of about 152,526 (259)

THE THALAMUS [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1967
openaire   +2 more sources

The thalamus [PDF]

Comparative Biochemistry and Physiology Part A: Physiology, 1987
openaire   +2 more sources

Advances in neuroimaging studies of thalamic abnormalities in children with attention deficit hyperactivity disorder. [PDF]

Psychoradiology
Zhou J, Jin R, Zhu T, Yu J, Cen X, Feng Q, Mo Y, Zhang M, Zheng W, Wang Y, Huang R, Li H, Yang C.   +12 more
europepmc   +1 more source

Preclinical serum alterations and tissue changes in protein and gene expression of early cerebrospinal fluid-validated biomarkers in scrapie. [PDF]

Vet Res
Pérez-Lázaro S, Barrio T, Sevilla E, Bolea R, Badiola JJ.   +4 more
europepmc   +1 more source

Deep brain stimulation of the thalamus for intractable epilepsy (FRANCE study): A randomized clinical trial

Epilepsia, EarlyView.
Abstract Objective This study was undertaken to evaluate the efficacy and safety of deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) compared with best medical treatment (BMT) in patients with drug‐resistant epilepsy (DRE).
Stéphan Chabardès, Fabrice Bartolomei, Anca Nica, Claire Haegelen, Lorella Minotti, Brigitte Piallat, Chrystele Mosca, Sandrine Massicot, Sylvain Rheims, Marc Guenot, Emmanuel Cuny, Jérome Aupy, Louis Maillard, Sophie Colnat‐Coulbois, Corentin Leroy, Romain Carron, Philippe Coubes, Philippe Gélisse, Carine Karachi, Vincent Navarro, Bertrand Devaux, Francine Chassoux, Phlippe Derambure, Nicolas Reyns, Jean Christope Sol, Luc Valton, Denys Fontaine, Veronique Bourg, Philippe Kahane, Sandra David‐Tchouda, Jean Regis   +30 more
wiley   +1 more source

Pulvinar and total thalamus volumes are preserved following early monocular enucleation. [PDF]

Front Neurosci
Moro SS, Cohan R, Steeves JKE.
europepmc   +1 more source

Artificial intelligence for adaptive neuromodulation in drug‐resistant epilepsy

Epilepsia, EarlyView.
Abstract Drug‐resistant epilepsy (DRE) affects nearly one third of people with epilepsy and is associated with substantial cognitive, psychiatric, and mortality burdens. For patients who are not candidates for resection or laser interstitial thermal therapy, neuromodulation therapies such as vagus nerve stimulation, deep brain stimulation, and ...
Amir Hossein Daraie, Arianna Damiani, Mahsa Khoshkhou, Luis A. Sanchez, Rachel J. Smith, Shruti H. Agashe, Jorge A. Gonzalez‐Martinez, Jennifer Hopp, Adam S. Charles, Sridevi V. Sarma, Joon‐Yi Kang   +10 more
wiley   +1 more source

Thalamic interictal epileptic and non-epileptic events during NREM sleep in patients with focal epilepsy: a Stereo-EEG study. [PDF]

EBioMedicine
Ye H, Jaber K, Ho A, Ye L, Thomas J, Xu X, Chen C, Chen Y, Ren G, Moye M, Avigdor T, Doležalová I, Klimes P, Parikh P, Southwell D, Zheng Z, Zhu J, Wang S, Frauscher B.   +18 more
europepmc   +1 more source

Targeted senotherapy improves electrographic and behavioral outcomes in a mouse model of temporal lobe epilepsy

Epilepsia, EarlyView.
Abstract Objective Current pharmacotherapy for temporal lobe epilepsy (TLE) is limited to symptomatic treatment and leaves approximately one third of patients with inadequate seizure control. Discovering disease‐modifying targets is an unmet clinical need. We have previously identified senescent cells (SCs) as one such target. Many drugs that eliminate
David J. McFall, Abbas I. Hussain, Michelle Cho, Patrick A. Forcelli   +3 more
wiley   +1 more source

Glymphatic dysfunction contributes to thalamic iron retention and secondary thalamic injury after stroke: evidence from primates and rodents. [PDF]

J Neuroinflammation
Wei J, Chen X, Lei Q, Xie J, Long X, Xiong Z, Yang M, Zha L, Huang W, Ouyang F, Zeng J.   +10 more
europepmc   +1 more source